Showing results (341-350 of 590) with videos related to
Sort By:
Pageof 59
Cerebral Circulation - Cognition and Behavior|September 12, 2024
The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years?Atticus H Hainsworth, Thomas P Blackburn, Elizabeth M Bradshaw, et al.Arthritis Care & Research|December 17, 2013
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritisLis Cordingley, Rita Prajapati, Darren Plant, et al.Journal of Leukocyte Biology|April 24, 2008
Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cellsAmy E Anderson, Bethan L Sayers, Muzlifah A Haniffa, et al.Pharmacogenetics and Genomics|March 20, 2010
Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment responseCatherine Potter, Laura J Gibbons, John D Bowes, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2007
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral bloodHeike Runne, Alexandre Kuhn, Edward J Wild, et al.Environmental Science and Pollution Research International|January 9, 2019
Tailoring the textural properties of an activated carbon for enhancing its adsorption capacity towards diclofenac from aqueous solutionAdriana I Moral-Rodríguez, Roberto Leyva-Ramos, Conchi O Ania, et al.Rheumatology (Oxford, England)|September 13, 2014
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJames Bluett, Catharine Morgan, Layla Thurston, et al.Chembiochem : a European Journal of Chemical Biology|June 6, 2017
Traceless Cleavage of Protein-Biotin Conjugates under Biologically Compatible ConditionsJoseph Cowell, Matthew Buck, Ali H Essa, et al.Arthritis Research & Therapy|October 9, 2012
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortDarren Plant, Ibrahim Ibrahim, Mark Lunt, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Pim Kinases as Therapeutic Targets in Early Rheumatoid ArthritisNicola J Maney, Henrique Lemos, Ben Barron-Millar, et al.Pageof 59